Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002234851 | SCV000953557 | likely benign | HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED | 2024-04-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002424913 | SCV002681040 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-02-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003323731 | SCV004029481 | likely benign | not specified | 2023-07-29 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000813211 | SCV001462120 | uncertain significance | Classic homocystinuria | 2020-09-16 | no assertion criteria provided | clinical testing |